Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Graziana Petracca"'
Autor:
Alessandro Mantovani, Giorgia Beatrice, Graziana Petracca, Filippo Pampagnin, Damiano Sandri, Giovanni Targher
Publikováno v:
Exploration of Medicine, Vol 1, Iss 3, Pp 108-123 (2020)
Aim: Recent randomized controlled trials (RCTs) have tested the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RA) to specifically treat non-alcoholic fatty liver disease (NAFLD). We performed a meta-analysis of RCTs to investigate the
Externí odkaz:
https://doaj.org/article/320af9e16ef243f696f30530716c9937
Autor:
Alessandro Mantovani, Alessandro Csermely, Elena Sani, Giorgia Beatrice, Graziana Petracca, Gianluigi Lunardi, Stefano Bonapace, Giuseppe Lippi, Giovanni Targher
Publikováno v:
Biomolecules, Vol 12, Iss 7, p 943 (2022)
Background: Although ceramides are involved in the pathophysiology of cardiovascular disease and other inflammation-associated disorders, there is a paucity of data on the association between plasma ceramides and inflammatory biomarkers in type 2 dia
Externí odkaz:
https://doaj.org/article/0116844bb973421690afbf93045fe280
Autor:
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Amedeo Lonardo, Giovanni Targher
Publikováno v:
Metabolites, Vol 11, Iss 2, p 73 (2021)
To assess the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for treatment of nonalcoholic fatty liver disease (NAFLD) or steatohepatitis (NASH), we performed a systematic review and meta-analysis of randomized controlled trials (R
Externí odkaz:
https://doaj.org/article/7de0f2a32737421699993bab860af212
Autor:
Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, Giorgia Beatrice, Giovanni Targher
Publikováno v:
Metabolites, Vol 11, Iss 1, p 22 (2020)
Recent randomized controlled trials (RCTs) tested the efficacy of sodium-glucose cotransporter-2 (SGLT-2) inhibitors to specifically treat nonalcoholic fatty liver disease (NAFLD). We systematically searched three electronic databases (up to 31 Octob
Externí odkaz:
https://doaj.org/article/ffce98abf25a48eba458223a94c765ec
Autor:
Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, Giorgia Beatrice, Stefano Bonapace, Andrea Rossi, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Publikováno v:
Gut. 72:372-380
ObjectiveRecent studies reported an association between non-alcoholic fatty liver disease (NAFLD) and increased risk of new-onset heart failure (HF). However, the magnitude of the risk and whether this risk changes with severity of liver disease rema
Autor:
Christopher D. Byrne, Alessandro Csermely, Kathleen E. Corey, Giorgia Beatrice, Giovanni Targher, Graziana Petracca, Tracey G. Simon, Alessandro Mantovani
Publikováno v:
The Lancet Gastroenterology & Hepatology. 6:903-913
Summary Background Studies have reported a significant association between non-alcoholic fatty liver disease (NAFLD) and increased incidence of cardiovascular disease (CVD). However, the magnitude of the risk and whether this risk changes with the se
Autor:
Giorgia Beatrice, Filippo Pampagnin, Graziana Petracca, Alessandro Mantovani, Giovanni Targher, Damiano Sandri
Publikováno v:
Exploration of Medicine, Vol 1, Iss 3, Pp 108-123 (2020)
Aim: Recent randomized controlled trials (RCTs) have tested the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RA) to specifically treat non-alcoholic fatty liver disease (NAFLD). We performed a meta-analysis of RCTs to investigate the
Autor:
Giorgia Beatrice, Herbert Tilg, Giovanni Targher, Alessandro Mantovani, Graziana Petracca, Christopher D. Byrne, Alessandro Csermely
ObjectiveWe performed a meta-analysis of observational studies to quantify the magnitude of the association between non-alcoholic fatty liver disease (NAFLD) and risk of extrahepatic cancers.DesignWe systematically searched PubMed, Scopus and Web of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b8535175e3d480e4d4ddf49a276326
http://hdl.handle.net/11562/1059037
http://hdl.handle.net/11562/1059037
Autor:
Alessandro Mantovani, Stefano Bonapace, Clementina Dugo, Giorgia Beatrice, Graziana Petracca, Davide Cappelli, Alessandro Csermely, Giulio Molon, Giovanni Targher
Publikováno v:
International journal of cardiology. 353
The association between serum uric acid (SUA) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in patients with coronary artery disease (CAD) is unclear.We retrospectively studied 171 patients with suspected or established CAD
Autor:
Giovanni Targher, Christopher D. Byrne, Giorgia Beatrice, Herbert Tilg, Graziana Petracca, Alessandro Mantovani
ObjectiveFollow-up studies have shown that non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of incident diabetes, but currently, it is uncertain whether this risk changes with increasing severity of NAFLD. We performed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5441f5b68126eb047a29ac9f5f49d4c8
http://hdl.handle.net/11562/1041600
http://hdl.handle.net/11562/1041600